Phase 1 CMV Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
Kidney Transplant; ComplicationsCMV
University of Minnesota30 enrolled1 locationNCT07096453
Recruiting
Phase 1
Expansion of Virus-Specific Lymphocytes for Cell Therapy
CMV ViremiaCMV
Hospital Israelita Albert Einstein10 enrolled1 locationNCT06011486
Completed
Phase 1
T-cell Therapy for CMV (Cytomegalovirus) Disease
CMV disease
Queensland Institute of Medical Research30 enrolled1 locationACTRN12609000531213
Recruiting
Phase 1
A phase 1 clinical trial of peptide-pulsed monocyte-derived dendritic cell vaccination to expand adoptively transferred cytomegalovirus -specific cytotoxic T lymphocytes after allogeneic stem cell transplantation
Cytomegalovirus (CMV) reactivation and disease
Western Sydney Local Health District18 enrolled1 locationACTRN12608000458336